Multi-platform characterization of the human cerebrospinal fluid metabolome: A comprehensive and quantitative update

Genome Medicine

Volumn 4, Issue 4, 2012, Pages

  Mandal, Rupasri ^a   Guo, An Chi ^a   Chaudhary, Kruti K ^a   Liu, Philip ^a   Yallou, Faizath S ^a   Dong, Edison ^a   Aziat, Farid ^a   Wishart, David S ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b NATIONAL RESEARCH COUNCIL CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACYLCARNITINE; AMINO ACID; HEXOSE; LYSO PHOSPHATIDYLCHOLINE DERIVATIVE; PHOSPHATIDYLCHOLINE; SPHINGOLIPID; UNCLASSIFIED DRUG;

ARTICLE; CEREBROSPINAL FLUID; DIRECT FLOW INJECTION MASS SPECTROMETRY; HUMAN; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; METABOLITE; METABOLOME; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL;

EID: 84860424898     PISSN: None     EISSN: 1756994X     Source Type: Journal    
DOI: 10.1186/gm337     Document Type: Article

References (18)

1. Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, Cheng D, Jewell K, Arndt D, Sawhney S, Fung C, Nikolai L, Lewis M, Coutouly MA, Forsythe I, Tang P, Shrivastava S, Jeroncic K, Stothard P, Amegbey G, Block D, Hau DD, Wagner J, Miniaci J, Clements M, Gebremedhin M, Guo N, Zhang Y, Duggan GE, Macinnis GD, et al. HMDB: the Human Metabolome Database. Nucleic Acids Res 2007, 35(Database issue):D521-6. 1899095, 17202168.
2. Wishart DS, Lewis MJ, Morrissey JA, Flegel MD, Jeroncic K, Xiong Y, Cheng D, Eisner R, Gautam B, Tzur D, Sawhney S, Bamforth F, Greiner R and LL. The human cerebrospinal fluid metabolome. J Chrom B 2008, 871:164-173.
3. Hoffmann G, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan W. Physiology and pathophysiology of organic acids in cerebrospinal fluid. J Inherit Metab Dis 1993, 16:648-669. 10.1007/BF00711898, 8412012.
4. Toczylowska B, Chalimoniuk M, Wodowska M, Mayzner-Zawadzka E. Changes in concentration of cerebrospinal fluid components in patients with traumatic brain injury. Brain Res 2006, 1104:183-189. 10.1016/j.brainres.2006.05.057, 16793028.
5. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol 2006, 5:228-234. 10.1016/S1474-4422(06)70355-6, 16488378.
6. Jimenez-Jimenez FJ, Rubio JC, Molina JA, Martin MA, Campos Y, Benito-Leon J, Orti-Pareja M, Gasalla T, Arenas J. Cerebrospinal fluid carnitine levels in patients with Parkinson's disease. J Neurol Sci 1997, 145:183-185. 10.1016/S0022-510X(96)00259-6, 9094047.
7. Simone IL, Federico F, Trojano M, Tortiralla C, Liguori M, Giannini P, Piccola E, Natile G, Livrea P. High resolution proton MR spectroscopy of cerebrospinal fluid in MS patients. Comparison with biochemical changes in demyelinating plaques. J Neurol Sci 1996, 144:182-190. 10.1016/S0022-510X(96)00224-9, 8994122.
8. HMDB CSF Metabolome Toolbox. , http://www.csfmetabolome.ca
9. Lutz NW, Cozzone PJ. Metabolic profiling in multiple sclerosis and other disorders by quantitative analysis of cerebrospinal fluid using nuclear magnetic resonance spectroscopy. Curr Pham Biotech 2011, 12:1016-10125.
10. Ng DJY, Pasikanti KK, Chan ECY. Trend analysis of metabonomics and systematic review of metabonomics-derived cancer marker metabolites. Metabolomics 2011, 7:155-178.
11. Blasco H, Corcia P, Moreau C, Veau S, Fournier C, Vourc'h P, Emond P, Gordon P, Pradat PF, Praline J, Devos D, Nadal-Desbarats L, Andres CR. 1H-NMR-Based metabolomic profiling of CSF in early amyotrophic lateral sclerosis. PLoS ONE 2010, 5:e13223. 10.1371/journal.pone.0013223, 2951909, 20949041.
12. The Automated Mass Spectral Deconvolution and Identification System (AMDIS). , http://chemdata.nist.gov/mass-spc/amdis/
13. NIST 08 (2008) Mass spectral library (NIST/EPA/NIH) Gaithersburg, USA: National Institute of Standards and Technology, NIST 08 (2008).
14. Wishart DS, Knox C, Guo AC, Eisner R, Young N, Gautam B, Hau DD, Psychogios N, Dong E, Bouatra S, Mandal R, Sinelnikov I, Xia J, Jia L, Cruz JA, Lim E, Sobsey CA, Shrivastava S, Huang P, Liu P, Fang L, Peng J, Fradette R, Cheng D, Tzur D, Clements M, Lewis A, De Souza A, Zuniga A, Dawe M, et al. HMDB: a knowledgebase for the human metabolome. Nucleic Acids Res 2009, 37(Database issue):D603-10. 2686599, 18953024.
15. Bogumil R, Rohring C, Dammeier S, Namendorf C, Uhr M. Targeted Metabolomics Analysis of Cerebrospinal Fluid Using the AbsoluteIDQ™ Kit. Application Note 1003-1 Innsbruck, Austria: Biocrates Life Sciences., http://www.biocrates.com/images/stories/pdf/Folders/Factsheets_etc/biocrates%20application%20note%201003-1_csf.pdf
16. Cava-Montesinos P, Cervera ML, Pastor A, de la Guardia M. Room temperature acid sonication ICP-MS multielemental analysisof milk. Anal Chim Acta 2005, 531:111-123.
17. Molina-Holga F, Hider RC, Gaeta A, Williams R, Francis P. Metals ions and neurodegeneration. Bioimetals 2007, 20:639-654.
18. Michalke B, Nischwitz V. Review on metal speciation in cerebrospinal fluid - current methods and results: a review. Anal Chim Acta 2010, 682:23-36. 10.1016/j.aca.2010.09.054, 21056712.